Carle Cancer Center Community Clinical Oncology Program

卡尔癌症中心社区临床肿瘤学项目

• 批准号: 6900327
• 负责人: KENDRITH Martin ROWLAND
• 金额: $ 97.58万
• 依托单位: CARLE FOUNDATION
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-06-01 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6900327
• 关键词: breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; clinical research; clinical trials; community health services; cooperative study; data management; female; health services research tag; human subject; human therapy evaluation; medical rehabilitation related tag; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer education; neoplasm /cancer therapy; nicotine replacement; phytoestrogens; sign /symptom; smoking cessation

DESCRIPTION (provided by applicant): In response to RFA CA-03-011 Community Clinical Oncology Program, National Cancer institute, the Carle Cancer Center, Urbana, Illinois is making an application to continue to be designated as a CCOP in East Central Illinois. As the second largest private medical group practice in Illinois, with nearly 300 physicians, the Carle Clinic Association has a fully developed community cancer center program, which has been involved in national clinical trials research since 1976. The Carle Cancer Center has been continuously funded as a CCOP since the program's inception in 1983. Joining Carle in this CCOP application as component institutions are the Joliet Oncology Hematology Associates in Joliet, Illinois, Rush-Copley Cancer Center in Aurora, Illinois, and the National Cancer Institute of Mexico in Mexico City, Mexico. The combined Carle Cancer Center CCOP provides services to cancer patients from a large catchment area of 38 counties in east central Illinois and western Indiana, 4 counties south and southwest of Chicago, Illinois and in Mexico City, Mexico. The headquarters for the CCOP is located at the Carle Cancer Center with all randomizations, administrative matters and quality assurance programs managed in Urbana, Illinois. The CCOPs primary research base is the North Central Cancer Treatment Group. There are also strong affiliations with the Eastern Cooperative Oncology Group and the National Surgical Adjuvant Breast and Bowel Project. A new affiliation with the MD Anderson Cancer Center was begun in 2001. The Carle Cancer Center and it's affiliates have dedicated clinical research associates, nurses, and administrative staff to assist 30 investigating medical and radiation oncologists in placing patients and participants on clinical research trials that should result in approximately 135 treatment credits and 210 cancer control credits annually. The goal of the Carle Cancer Center CCOP is to provide progressive state of the art cancer care and prevention to individuals within their own communities. To this end, access and participation in NCI clinical trials of cancer prevention, detection and treatment offer the highest standard of care and the brightest hope for the future.

描述（由申请人提供）：为响应国家癌症研究所RFA CA-03-011社区临床肿瘤学项目，伊利诺伊州厄巴纳市卡尔癌症中心正在申请继续被指定为伊利诺伊州中东部的CCOP。作为伊利诺伊州第二大私人医疗集团，拥有近300名医生，Carle Clinic Association拥有一个完善的社区癌症中心计划，自1976年以来一直参与国家临床试验研究。自1983年该计划成立以来，卡尔癌症中心一直作为CCOP获得持续资助。作为组成机构加入Carle的CCOP应用程序的是伊利诺伊州乔利埃特的乔利埃特肿瘤血液学协会、伊利诺伊州奥罗拉的拉什-科普利癌症中心和墨西哥墨西哥城的墨西哥国家癌症研究所。合并后的卡尔癌症中心CCOP为来自伊利诺伊州中东部和印第安纳州西部38个县、伊利诺伊州芝加哥南部和西南部4个县以及墨西哥墨西哥城的癌症患者提供服务。CCOP的总部位于Carle癌症中心，所有随机化、行政事务和质量保证计划均在伊利诺伊州厄巴纳管理。CCOPs的主要研究基地是北中央癌症治疗小组。与东部肿瘤协作组和国家外科辅助乳腺和肠道项目也有很强的联系。2001年，与MD安德森癌症中心建立了新的联系。的 卡尔癌症中心及其附属机构有专门的临床研究助理，护士和行政人员，以协助30调查医疗和放射肿瘤学家在放置患者和参与者的临床研究试验，应导致每年约135治疗学分和210癌症控制学分。卡尔癌症中心CCOP的目标是为社区内的个人提供先进的癌症护理和预防。为此，获得和参与NCI癌症预防、检测和治疗的临床试验，为未来提供了最高标准的护理和最光明的希望。